OLIX PHARMACEUTICALS INC.
{{company.company_channel.channel_name}}
Media Room
{{company.company_name_local}}
{{company.company_channel.channel_name}}
Company Profile
Media Room
OliX Pharmaceuticals Identifies Inhibition of Target Gene Expression in Nonhuman Primate Models for NASH Candidate 2022-04-08 20:00
OliX Pharmaceuticals Expands Ocular Disease Pipeline; Adds OLX304A for the Treatment of Retinitis Pigmentosa 2019-05-10 09:24
OliX Pharmaceuticals Announces The Ophthalmologist Demetrios G. Vavvas, M.D., Ph.D., to join Scientific Advisory Board 2019-04-22 13:32
Théa and OliX Announce Collaboration to Develop RNAi Therapies for the Treatment of AMD 2019-03-18 23:58
OliX Announces Clinical Candidate Nomination for the Treatment of Geographic Atrophy 2019-01-18 14:50
OliX, a RNAi therapeutics developer, gets approval for KOSDAQ listing 2018-07-23 14:42
1